Steven B. Ketchum
EVP, Chief Scientific Officer · AMARIN CORP PLC\UK
Individual
- 2026
- Jul 15, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Steven B. Ketchum's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven B. Ketchum?
Steven B. Ketchum is a corporate insider, tracked as EVP, Chief Scientific Officer of AMARIN CORP PLC\UK (AMRN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Steven B. Ketchum last file a Form 4?
The most recent primary Form 4 on record is dated 15 July 2026, one of 3 filings going back to 2026.
